With two years of COVID-19 experience and uncertainty around the omicron variant, it is clear that prompt access to new medicines and vaccines will be absolutely vital as we deal with future waves of this pandemic, and prepare for the next one. This will require innovation in Canada and globally. And it will require international coordination and planning to avoid the enormous challenges to global vaccine development, production and distribution that we saw when countries raced to first acquire doses. Our experts tackle these issues in two panels.
